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INTRODUCTION
The presence of multidrug resistant organisms (MDROs) is not a problem limited to hospitals. 
MDROs, such as methicillin resistant Staph aureus (MRSA), vancomycin-resistant enterococci 
(VRE), drug resistant Streptococcus pneumoniae, and multidrug resistant gram-negative bacteria 
are important causes of colonization and infection in long term care facilities (LTCFs).
In LTCFs, many residents are colonized with MDROs on transfer from acute-care hospitals or 
other healthcare facilities. Colonized residents are a concern for LTCFs because they can cause 
increased morbidity and mortality, and are costly to treat. Once MDROs, such as MRSA and 
VRE, have become established in a facility, they are rarely eliminated. Effective infection control 
policies and procedures are essential to prevent the transmission of MDROs, but application of 
hospital infection control guidelines to LTCFs is often unrealistic. The facility is also the 
resident’s home and every effort must be made to allow residents to ambulate, socialize and 
participate in group activities.  Since many residents interact freely with each other, controlling 
transmission in this setting is challenging and the psychosocial needs of the residents must be 
balanced with good infection control practices.
COLONIZATION AND INFECTION
In order to implement infection control measures to prevent the spread of MDROs in LTCFs, it is 
important for healthcare workers to understand the differences between colonization and 
infection. 
• Colonization:  MDRO is present in or on a body site; no clinical signs or symptoms of 
illness or infection are present. A colonized person is sometimes referred to as a “carrier”. 
• Infection:  Presence of an MDRO in a body site accompanied by clinical signs and 
symptoms of infection (e.g., fever, lesions, wound drainage) or increased white blood cell 
count. Infection usually warrants treatment.
Note: Infection or colonization with an MDRO is not valid grounds for denial of admission to  
a long term care facility.
Infectious Agents: 
MDROs are defined as microorganisms, predominantly bacteria, that are resistant to one or more 
classes of antimicrobial agents. Although the names of some of the MDROs describe resistance to 
only one agent (e.g. MRSA, VRE, VISA, VRSA), these pathogens are frequently resistant to many 
available antimicrobial agents.
 
Massachusetts Department of Public Health, Division of Epidemiology and Immunization
MRSA (methicillin resistant S. aureus) is a S. aureus (“staph”) bacterium that is resistant to beta-
lactam antibiotics, including methicillin, oxacillin, penicillin and amoxicillin. It is often resistant 
to many other antibiotics as well.
VRE (vancomycin resistant enterococcus) is an enterococcus with resistance to vancomycin.
VISA (vancomycin intermediate S. aureus) and VRSA (vancomycin resistant S. aureus) are 
strains of S. aureus that are resistant to most antibiotics, including having intermediate or greater 
resistance to vancomycin.
Beta-lactamases are enzymes produced by certain gram-negative and gram-positive bacteria such 
as Staph aureus, Klebsiella pneumoniae and Escherichia coli. These beta-lactamases disrupt the 
actions of certain antibiotics, such as penicillin, ampicillin and cephalosporins, making them 
ineffective. Later cephalosporins, i.e. extended spectrum cephalosporins, were originally resistant 
to the actions of these beta-lactamases and, therefore, effective against many bacteria. In the 
mid-1980’s, however, it became evident that a new type of beta-lactamase was being produced by 
K. pneumoniae and E. coli that could render these newer antibiotics ineffective. The organisms 
that produce these extended spectrum beta-lactamases are being collectively called ESBLs.
In addition to the above named MDROs there are others such as multi-drug resistant S.  
pneumoniae, K. pneumoniae carbapenemase (KPC)-producing organisms, Acinetobacter 
baumannii and Stenotrophomonas maltiphilia and more to come that can and will be of concern.
Reservoir: Colonized and infected patients serve as the major reservoir of MDROs in LTCFs. 
Some U.S. facilities have reported rates of colonization with MRSA as high as 30%. Colonization 
with MDROs may be transient or persistent, at a single site or multiple body sites. The nose 
(anterior nares) is the most common site of colonization with MRSA and other staph in both 
residents and healthcare providers. VRE typically colonizes the bowel, skin and wounds.    
Other sites of colonization with MDROs include the axilla, perineum, wounds, tracheostomy sites 
and venous catheter exit sites. In LTCF residents, MRSA is commonly isolated from urinary 
catheters and gastrostomy tube exit sites.  
Mode of Transmission: MDROs are primarily transmitted from patient to patient via the 
hands of healthcare workers. Hands may become contaminated by contact with: a) colonized or 
infected patients; b) colonized or infected body sites of the personnel themselves; or c) devices, 
items, or environmental surfaces contaminated with body fluids containing these organisms. 
Cleaning and disinfection of patient care items and environmental surfaces are essential to reduce 
bacterial load and risk of transmission. Droplet transmission is less common but may be important 
in patients with tracheostomies who are not able to control their secretions. 
Incubation Period: Variable and dependent on the MDRO. 
Risk factors for transmission of MDROs in LTCFs:
• Elderly and disabled residents 
• Length of stay
MDRO Page 2 of 9 Revised 9/25/2009
Massachusetts Department of Public Health, Division of Epidemiology and Immunization
• Accommodation in rooms with multiple beds
Both colonized and infected residents may serve as sources for spread of MDROs in LTCFs. 
Since colonization may persist for long periods of time, LTCFs can expect infections with 
MDROs to be a continuing problem.
Diagnosis and testing:  Colonization/infection with an MDRO is diagnosed by a bacterial 
culture, antibiotic susceptibility testing, and other specific laboratory tests, along with clinical 
signs/symptoms of infection.  The site for culture will depend on the particular MDRO and the 
signs and symptoms that the patient is exhibiting. For example, common sites of infection (and 
colonization) for MRSA, VISA and VRSA include wounds, tracheostomy sites, respiratory tract 
of intubated patients, and IV catheter sites. To detect colonization in the asymptomatic client or 
health care worker, specimens are usually obtained from the skin, nares or rectum.
Treatment: Issues relating to the treatment of an infection or colonization with an MDRO, 
including what or if antibiotics are appropriate, should be addressed by the patient’s physician. 
The occurrence and persistence of MDROs in LTCFs has been strongly associated with antibiotic 
use.  A common problem is the failure to distinguish infection from colonization and the 
treatment of colonization with antibiotics.
PREVENTION AND CONTROL
There are several types of interventions used to control the spread of MDROs in LTCFs. These 
include administrative measures, education, surveillance, infection control, environmental 
measures, judicious antibiotic usage, decolonization, communication and outbreak control 
measures.
Administrative Measures
Authorities in infection prevention have strongly recommended administrative support and 
involvement in efforts to control MDROs in LTCFs. Interventions, such as providing the 
necessary number and appropriate placements of handwashing sinks and hand sanitizer 
dispensers, maintaining appropriate staffing levels and enforcing adherence to recommended 
infection control practices all require the cooperation and involvement of administration. 
Surveillance
Surveillance is an important component of all long term care infection control programs. 
Surveillance should include maintaining a confidential line listing of residents colonized and/or 
infected with targeted MDROs. Monitoring culture and antibiotic susceptibility data will help 
determine baseline rates for MDROs in a facility, indicate the occurrence of increased 
transmission, and monitor the effectiveness of outbreak control measures. In some health care 
settings it may be appropriate to use active surveillance cultures to identify patients who are 
colonized with a targeted MDRO, but this would rarely be the case in a LTCF. 
Antibiotic Use
The appropriate and prudent use of antimicrobials is a key component in controlling antibiotic 
resistance. LTCFs should develop and institute programs and policies to monitor and control the 
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use of antimicrobials. The CDC Campaign to Prevent Antimicrobial Resistance that was launched 
in 2002 provides guidance for judicious use of antimicrobials and tools for implementation and 
can be found at: http://www.cdc.gov/drugresistance/healthcare/default.htm  .  This effort targets all 
healthcare settings including long term care and focuses on effective antimicrobial treatment of 
infections, use of narrow spectrum agents, avoiding excessive duration of therapy and restricting 
use of more potent antibiotics to the treatment of serious infections.
Infection Control
Implementation of, and adherence to, infection control practices are key to preventing the 
transmission of infectious diseases in all healthcare facilities. 
Standard Precautions should be used consistently and at all times, by all staff, in LTCFs. Most 
residents with MDROs can be cared for using Standard Precautions, with an emphasis on strict 
adherence to hand hygiene and appropriate glove us. General infection control measures, 
including Standard Precautions for healthcare providers can be found at: 
http://www.mass.gov/Eeohhs2/docs/dph/cdc/infection_control/general_measures.pdf 
Contact Precautions may be indicated for residents with MDROs. Consider the resident’s 
individual clinical situation and the prevalence or incidence of the particular MDRO in the facility 
when deciding whether to implement Contact Precautions for a resident infected or colonized with 
an MDRO. 
• Healthy residents  : For relatively healthy and mainly independent residents, follow 
Standard Precautions, making sure that gloves and gowns are used for contact with 
uncontrolled secretions, pressure ulcers, draining wounds, stool incontinence, and ostomy 
tubes/bags.
• Ill residents  : For those residents who are ill, or totally dependent upon healthcare 
personnel for healthcare activities of daily living, or ventilator-dependent, and for those 
residents whose infected secretions or drainage cannot be contained, use Contact  
Precautions in addition to Standard Precautions.
Room Placement:  In LTCFs, decisions regarding patient placement should be made on a case-by-
case basis, balancing infection risks to other patients in the room, the presence of risk factors that 
increase the likelihood of transmission, and the potential adverse psychological impact on the 
infected or colonized patient.
 
• A single patient room is preferred for patients who require Contact Precautions. If single 
rooms are not available, consultation with infection control personnel is recommended to 
decide which residents with MDROs can be cohorted. If cohorting is not possible residents 
colonized or infected with MDROs should not be placed with roommates who are severely 
immunocompromised or have indwelling lines or open wounds.  
• In multi-patient rooms, >3 feet spatial separation between beds is advised to reduce the 
opportunities for inadvertent sharing of items between the infected/colonized patient and 
other patients. Draw the privacy curtain between beds to minimize opportunities for direct 
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contact. 
• Change protective attire and perform hand hygiene between contact with patients in the 
same room, regardless of whether one or both patients are on Contact Precautions. 
Group Activities:  MDRO colonized or infected residents should be allowed to ambulate, socialize 
as usual, and participate in therapeutic and group activities as long as contaminated body 
substances are contained.  Hand hygiene is an important component of participation in group 
activities. When residents leave their room, they should have their hands cleaned.  In addition, 
they should have clean, dry dressings and wear clean clothes.  Where appropriate, enhanced 
barrier protection to contain a contaminated body substance is preferred over restriction of the 
resident.
Hand Hygiene:  Handwashing is the single most effective measure to prevent the spread of 
MDROs.  Strict adherence to hand hygiene protocols must be maintained. Hand hygiene should 
be performed:
• After touching blood, body fluids, secretions, excretions, and contaminated items. 
• Immediately after gloves are removed, between patient contacts, and when otherwise 
indicated to avoid transfer of microorganisms to other patients or environments.
• When hands are visibly soiled with blood or other body fluids.
Both staff and visitors should wash their hands with soap and water after patient care, and prior to 
leaving the room of a MDRO-positive resident. Hands should be dried with a dry, disposable 
paper towel, and faucets should be turned off using a paper towel. The use of a waterless, 
alcohol-based hand antiseptic is as effective as soap and water for MDROs, is not harmful 
to hands, and may improve compliance.  However, these products are not a substitute for 
handwashing in the event of visible contamination.
Gloves: Don gloves upon entry into the room or cubicle. Gloves (clean non-sterile gloves are 
adequate) should be worn when providing care that involves substantial personal contact (e.g. 
changing clothes, toileting, bathing) or contact with items that may be contaminated by an MDRO 
(e.g. bedding). If, during the course of patient care, gloves become soiled with potentially 
infectious material (e.g. urine, stool), they should be changed before further contact with clean 
surfaces, the patient, or other staff.  Remove the gloves after caring for the patient and wash hands 
with soap and water or an alcohol based hand sanitizer before leaving the room.  Gloves alone do 
not guarantee prevention of transmission. Never wash gloves for the purpose of reuse. 
Gowns: Don gown upon entry into the room or cubicle. Remove gown and observe hand 
hygiene before leaving the patient-care environment. After gown removal, ensure that clothing 
and skin do not contact potentially contaminated environmental surfaces that could result in 
possible transfer of microorganism to other patients or environmental surfaces. 
Masks and Eye Protection: 
Eye protection or face shields should be worn during the care of any resident as part of Standard 
Precautions when performing procedures and patient-care activities that are likely to generate 
splashes or sprays of blood, body fluids, secretions and excretions. Such activities include wound 
irrigation, oral suctioning, intubation, and caring for a resident with open tracheostomy. You may 
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also want to consider wearing masks and eye protection while caring for residents with respiratory 
infections. Masks and eye protection are not otherwise recommended for prevention of MDRO 
transmission from residents to health care workers during routine care.
Patient care equipment and instruments/devices: Use disposable noncritical patient-care 
equipment (e.g., blood pressure cuffs) or implement patient-dedicated use of such equipment. If 
common use of equipment for multiple patients is unavoidable, clean and disinfect such 
equipment before use on another patient. Clean and disinfect surfaces that are likely to be 
contaminated with an MDRO, including those that are in close proximity to the patient (e.g., bed 
rails, over bed tables) and frequently-touched surfaces in the patient care environment (e.g., door 
knobs, surfaces in and surrounding toilets in patients’ rooms) on a more frequent schedule 
compared to that for other surfaces.
Environmental Measures
Monitoring for adherence to environmental cleaning practices is an important component for 
controlling the transmission of all pathogens, including MDROs in LTCFs. Standard facility 
procedures should be followed for cleaning the rooms of residents with MDROs. Prioritize room 
cleaning of patients on Contact Precautions. Bath tubs, whirlpools, and hydrotherapy tubs should 
be cleaned and disinfected after each use.  Always consult your facility's housekeeping protocols 
first.  There are several disinfectant products on the market.  However, only those that are 
registered by the Environmental Protection Agency (EPA) as a hospital-grade disinfectant should 
be used.  A list of EPA registered disinfectants may be obtained by calling the National Pesticide 
Information Center at 800-858-7378 or by visiting 
http://www.epa.gov/oppad001/chemregindex.htm .  
Solutions of 5.25% sodium hypochlorite (household bleach) diluted to 1:64 with water (1/4 cup 
bleach to one gallon of water) are also acceptable for disinfection of environmental surfaces. Keep 
in mind, however, that bleach solutions can cause irritation of the skin, eyes, nose and respiratory 
system, and must be handled with care for the protection of staff and patients.  Avoid direct 
contact with skin and eyes and prepare bleach solutions in a well-ventilated area.  Bleach solutions 
need to be prepared daily.
Minimal handling of soiled linens should be stressed.  Staff involved with stripping beds or 
otherwise having direct contact with these materials should wear gloves and gowns.  Soiled linens 
should be bagged in the resident’s room.
Decolonization
Decolonization is sometimes considered to eliminate carriage of MRSA in an individual. This 
may decrease the risk of transmission to high-risk individuals or to others during an outbreak 
situation. While this approach has been used in a number of hospitals and LTCFs, it can result in 
increased antibiotic resistance. The effectiveness of decolonization is questionable and the 
routine culturing and decolonization of residents and staff for MRSA is not recommended. 
Measures to eradicate MRSA colonization have included the use of topical and/or oral antibiotic 
treatments and the use of antibacterial soaps. 
Special circumstances and medical reasons may warrant an attempt to decolonize residents or 
staff. They include the following:
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• During a MRSA outbreak, decolonization of residents and staff may be used to control the 
spread of the organism. 
• Staff implicated in transmission of MRSA are candidates for decolonization and should 
be treated and culture negative before being allowed to return to direct patient care.
• Residents who are immunocompromised and colonized and therefore are more likely to 
develop serious infections should be considered for decolonization.
• Residents who are more likely to spread the organism due to behavior (i.e. 
developmentally disabled or confused) or poor personal hygiene can also be considered.
Any attempt to decolonize should be made by an individual’s physician or after consultation  
with an infectious disease expert.
Note: Regimens and efficacy of decolonization protocols for MDROs other than MRSA, e.g. 
VRE and MDR-GNB, have not been established.
Education
Staff:  All staff working in a LTCF should receive education and training regarding MDROs and 
the importance of control. Education should be provided on a regular basis, at least annually. 
Additionally, in-service training in infection control should be provided in response to any 
increase in MDRO frequency within the facility. When educating staff about MDROs it should be 
reinforced that although healthcare workers are at risk for colonization, healthy people are at very 
little risk for developing an infection with an MDRO.
Resident, Family and Visitor: Residents and their families and visitors should be educated about 
MDROs and the rationale for the types of precautions used by the LTCF. Families and visitors 
must understand the importance of hand hygiene and should clean their hands before entering and 
leaving the room of a resident. In addition, families and visitors must have education to alleviate 
their concerns about MDROs, ensure that precautions are maintained, and understand that 
residents with MDROs do not need to be avoided. 
Communication with other Facilities
It is essential that LTCFs, hospitals and other healthcare organizations (e.g. home health care and 
VNAs) work together to control the spread of MDROs. Effective communication will ensure that 
the MDRO status of residents is known so that appropriate precautions are implemented in all 
healthcare settings. Identification of MDRO colonization/infection should be noted in the 
resident’s medical record, and notification should be given prior to transfer/travel to another 
facility.
OUTBREAK CONTROL
An outbreak may be defined as the occurrence of a disease or condition in excess of what is 
normally expected.  The common definition of an outbreak in LTCFs is: 1) several cases that are 
linked epidemiologically by person, time, or place, or 2) a substantial increase in the number of 
cases normally identified in a facility. Each case of an MDRO in a resident should be closely 
monitored as previously described. In addition, the following should be conducted in outbreak 
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situations:
1. Individual cases of MDROs are not presently reportable to the Massachusetts Department of 
Public Health.  However, in outbreak situations, notify the Department of Public Health, 
Division of Health Care Quality at (617) 753-8000 and the local board of health.  You should 
also contact the Division of Epidemiology and Immunization at (617) 983-6800 for additional 
advice.
2. Reinforce infection control procedures throughout the facility as described above. Institute 
Contact Precautions for residents who are positive for the outbreak MDRO.
3. Establish a cohort of residents who are positive for the outbreak MDRO. Staff should be 
restricted to caring for only one cohort of residents. Restrict floating of staff. 
4. Most often, environmental reservoirs of pathogens during outbreaks are related to a failure to 
follow recommended cleaning and disinfection procedures rather than the specific cleaning 
and disinfection product used. Intensify and reinforce education of housekeeping staff. Some 
facilities choose to assign designated staff to targeted resident care areas. Monitor cleaning 
performance to ensure compliance with disinfection of surfaces closest to the infected 
resident.
5. Culture all residents in the affected units. Obtain cultures from staff when there is 
epidemiologic evidence that might implicate a staff member as a source of ongoing 
transmission.
6. Collect the following information for each resident (case) positive for the outbreak MDRO:
a. location in the facility (before and after cohorting)
b. date(s) of the original and most recent admissions to the facility
c. date(s) of recent admissions/discharges to/from other acute and LTCFs
d. list of caregivers in the current facility who had "hands-on" contact 
e. body site(s) of infection/colonization 
f. age, sex, and ethnicity 
g. diagnosis and underlying conditions 
h. treatments given 
7. As previously mentioned, decolonization of residents or staff is not routinely recommended. 
This has not proven to be an effective control measure for large populations because 
recolonization occurs.  However, in an outbreak situation, when the MDRO is MRSA, if 
evidence implicates a colonized staff member or resident as a source of ongoing transmission 
then s/he should be removed from work while efforts are made to achieve decolonization 
(with infection control consultation). For specific information regarding decolonization see 
Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006 PDF (234KB/74 
pages).
 
8. Depending on the extent of the outbreak and the MDRO involved, restricting admissions to 
the facility may be considered while the outbreak is on-going.
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